Table 3. Primary outcome and clinical outcomes.

Outcomes	All patients (N = 81)	NMB (n = 38)	Placebo (n = 43)	p Value
Primary outcome
Serum lactate at 24 hours	3.0 (1.7–4.3)	2.8 (1.2–4.0)	3.6 (1.8–5.2)	0.238
Clinical outcome
In-hospital mortality	40 (49.4)	17 (44.7)	23 (53.5)	0.432
Poor neurologic outcome (CPC 3 to 5)	61 (75.3)	29 (76.3)	32 (74.4)	0.843
Poor neurologic outcome (mRS 4 to 6)	62 (76.5)	29 (76.3)	33 (76.7)	0.964
Length of stay
ICU stay	7.4 (2.8–13.7)	8.0 (2.4–15.2)	6.4 (2.9–11.6)	0.481
Hospital stay	9.0 (3.0–18.0)	11.5 (2.0–21.3)	8.0 (3.0–18.0)	0.673
Discharge to home
All patients	15 (18.5)	7 (18.4)	8 (18.6)	0.983
Hospital survivors	15/41 (36.6)	7/21 (33.3)	8/20 (40.0)	0.658

NMB, neuromuscular blockade; CPC, cerebral performance category; mRS, modified Rankin score; ICU, intensive care unit